New psoriasis drug shows promise in Mid-Stage trial
NCT ID NCT06542614
Summary
This study tested an investigational drug called TQH3906 in 209 adults with moderate-to-severe plaque psoriasis. The main goal was to see if the drug safely reduces the severity of skin plaques and improves patients' quality of life over 12 weeks. Researchers measured how much skin cleared and monitored for side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLAQUE PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Affiliated Hangzhou First People'S Hospital,School of Medicine, Westlake University
Hangzhou, Zhejiang, 310003, China
-
Beijing Tongren Hospital, Capital Medical University
Beijing, Beijing Municipality, 100730, China
-
Dermatology Hospital of Southern Medical University
Guangzhou, Guangdong, 510091, China
-
Genertec Liaoyou Gem Flower Hospital
Panjin, Liaoning, 124000, China
-
Heilongjiang Provincial Hospital
Harbin, Heilongjiang, 150036, China
-
Hospital of Dermatology, Chinese Academy of Medical Sciences
Nanjing, Jiangsu, 210000, China
-
Liuzhou People'S Hospital
Liuchow, Guangxi, 545006, China
-
Meihekou Central Hospital
Meihekou, Jilin, 135000, China
-
Nanyang First People'S Hospital
Nanyang, Henan, 473010, China
-
Qingdao Municipal hospital (group)
Qingdao, Shandong, 266011, China
-
Qingdao Traditional Chinese Medicine Hospital
Qingdao, Shandong, 266033, China
-
Shandong First Medical University Affiliated Dermatology Hospital
Jinan, Shandong, 250022, China
-
Shandong University Qilu Hospital
Jinan, Shandong, 250063, China
-
Shanghai JiaoTong University of medicine Ruijin Hospital
Shanghai, Shanghai Municipality, 20025, China
-
Shanxi Provincial People's Hospital
Taiyuan, Shanxi, 030012, China
-
Shengjing Hospital of China Medical University
Shenyang, Liaoning, 110000, China
-
Shijiazhuang Hospital of Traditional Chinese Medicine
Shijiazhuang, Hebei, 50000, China
-
Shiyan Renmin Hospital
Shiyan, Hubei, 442000, China
-
The First Affiliated Hospital of Baotou Medical College
Baotou, Inner Mongolia, 014000, China
-
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, 215006, China
-
The First Bethune Hospital of Jilin University
Changchun, Jilin, 130031, China
-
The First People's Hospital of Changde
Changde, Hunan, 415100, China
-
The Second Affiliated Hospital Of Xingtai Medical Colledge
Xingtai, Hebei, 054002, China
-
The Second Affiliated Hospital Zhejiang University School Of Medicine
Hangzhou, Zhejiang, 310009, China
-
The Second Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, 471000, China
-
The Second Affiliated Hospital of Wannan Medical College
Wuhu, Anhui, 241000, China
-
The Second Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, 710000, China
-
The Second Hospital of HeBei Medical University
Shijiazhuang, Hebei, 50000, China
-
The Third Xiangya Hospital of Central South University
Changsha, Hunan, 410000, China
-
The first affiliated hospital of chongqing medical university
Chongqing, Chongqing Municipality, 400042, China
-
The first hospital of china medical university
Shenyang, Liaoning, 110001, China
-
Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital
Tianjin, Tianjin Municipality, 300120, China
-
Wuhan First Hospital
Wuhan, Hubei, 430033, China
-
Xinjiang Uygur Autonomous Region People's Hospital
Ürümqi, Xinjiang, 830001, China
-
Yancheng First People's Hospital
Yancheng, Jiangsu, 224006, China
Conditions
Explore the condition pages connected to this study.